The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections

Arnaud John Kombe Kombe1, Leila Fotoohabadi1, Ravikanth Nanduri1

  • 1Division of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) activation protects against respiratory virus-induced airway injuries. Nrf2 pathway deregulation exacerbates damage, highlighting its therapeutic potential.

Area of Science:

  • * Molecular biology and immunology
  • * Pathophysiology of respiratory viral infections

Background:

  • * Respiratory viruses cause significant global morbidity and mortality.
  • * Associated injuries include oxidative stress, inflammation, and tissue damage.
  • * The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is implicated in cellular defense against viral damage.

Purpose of the Study:

  • * To review the role of Nrf2 activation in mitigating airway injuries caused by respiratory viruses.
  • * To discuss the impact of Nrf2 pathway status on viral-induced tissue damage.
  • * To highlight the potential of Nrf2 agonists as therapeutics for viral respiratory infections.

Main Methods:

  • * Literature review of studies investigating Nrf2 in viral respiratory infections.
  • * Analysis of Nrf2's involvement in cellular defense mechanisms.
  • * Examination of Nrf2's impact on various respiratory viruses (e.g., influenza, coronaviruses, rhinoviruses, RSV).

Main Results:

  • * Nrf2 pathway activation demonstrates protective effects against respiratory virus-induced airway and organ injuries.
  • * Inhibition or deregulation of Nrf2 exacerbates tissue damage during viral respiratory infections.
  • * Nrf2 plays a pivotal role in cellular defense against viral pathogens and associated complications.

Conclusions:

  • * Nrf2 activation is a key protective mechanism against respiratory virus-induced airway injuries.
  • * Targeting the Nrf2 pathway may offer therapeutic benefits for managing viral respiratory infections.
  • * Clinical trials are necessary to evaluate Nrf2 agonists for treating viral respiratory damage.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
129
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
770
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381